|

EAGD T-cell infusion (Expansion) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CliniMACS Alpha Beta T-Cell Depletion System, CliniMACS-Prodigy

Pipeline

Phase 1: 1

Top Sponsors

  • University of Kansas Medical Center1

Indications

  • Chronic Myeloid Leukemia1
  • Acute Myeloid Leukemia1
  • Acute Lymphoblastic Leukemia1
  • Myelodysplastic Syndromes1
  • Cancer1

Westwood, Kansas1 trial

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

University of Kansas Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.